GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better ...

The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...

The FDA has approved Eli Lillys Zepbound as the first weight-loss drug to treat obstructive sleep apnea, reshaping care for ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug ...

Oysters and manila clams harvested in Washington and British Columbia are being recalled. The FDA says the listed seafood ...

The Institute for Clinical and Economic Review assessed the formularies of 11 payers, covering 57 million people, to ...

Our top content from the 100th annual American Heart Association (AHA) Scientific Sessions included exclusive expert insights ...

Obesity continues to plague New Yorkers, affecting almost two out of every three adults in our state. That’s why I’m pushing ...

Richard Saynor sees opportunity in copying cutting-edge medication and extols the merits of being boring. Richard Saynor ...

With major changes coming to the Federal Employee Health Benefits (FEHB) plan, employees and retirees need to pay extra ...